Hot Features
Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-05-13 | Ms. Jane Okun BombaIndependent Director | -2,85k | 6,96k | Sale to Issuer | 2,44 | 349,43k | -0,81% |
| 2026-05-13 | Dr. Wendell E. PritchettIndependent Director | -3,37k | 8,22k | Sale to Issuer | 2,44 | 98,44k | -3,31% |
| 2026-05-13 | Dr. Saurabh SahaIndependent Director | -8,18k | 19,95k | Sale to Issuer | 2,44 | 108,34k | -7,02% |
| 2026-05-13 | Mr. Kenneth L. CornickIndependent Director | -5,99k | 14,62k | Sale to Issuer | 2,44 | 1,14M | -0,52% |
| 2026-05-13 | Mr. Andrew M. SnyderIndependent Non-Executive Chairman of the Board | -2,84k | 6,93k | Sale to Issuer | 2,44 | 446,94k | -0,63% |
| 2026-05-13 | Ms. Suzanne Elizabeth HeywoodIndependent Director | -19,69k | 48,04k | Sale to Issuer | 2,44 | 31,72k | -38,30% |
| 2026-05-01 | Mr. Henry LevyPresident of Life Sciences & Healthcare | -19,89k | 55,50k | Sale to Issuer | 2,79 | 983,37k | -1,98% |
| 2026-03-31 | Mr. Kenneth L. CornickIndependent Director | -2,27k | 5,75k | Sale to Issuer | 2,53 | 1,12M | -0,20% |
| 2026-03-31 | Mr. Andrew M. SnyderIndependent Non-Executive Chairman of the Board | -1,29k | 3,27k | Sale to Issuer | 2,53 | 410,31k | -0,31% |
| 2026-03-31 | Ms. Jane Okun BombaIndependent Director | -621,00 | 1,57k | Sale to Issuer | 2,53 | 290,01k | -0,21% |
| 2026-03-15 | Mr. William E. GraffExec. VP & Chief Information Officer | -23,84k | 61,26k | Sale to Issuer | 2,57 | 834,12k | -2,78% |
| 2026-03-15 | Mr. Matitiahu Shem TovCEO & Director | -125,47k | 322,46k | Sale to Issuer | 2,57 | 2,66M | -4,51% |
| 2026-03-15 | Mr. Michael EastonSenior VP of Finance & CAO | -30,46k | 78,27k | Sale to Issuer | 2,57 | 699,31k | -4,17% |
| 2026-03-13 | Mr. Michael EastonSenior VP of Finance & CAO | -26,50k | 0,00 | Other Disposition | - | 699,31k | -3,65% |
| 2026-03-15 | Mr. Jonathan M. CollinsExec. VP & CFO | -43,99k | 113,05k | Sale to Issuer | 2,57 | 1,15M | -3,70% |
| 2026-03-16 | Mr. Jonathan M. CollinsExec. VP & CFO | -35,74k | 0,00 | Other Disposition | - | 1,15M | -3,03% |
| 2026-03-15 | Mr. Henry LevyPresident of Life Sciences & Healthcare | -35,40k | 90,98k | Sale to Issuer | 2,57 | 1,00M | -3,41% |
| 2026-03-01 | Mr. William E. GraffExec. VP & Chief Information Officer | -20,83k | 47,90k | Sale to Issuer | 2,30 | 603,25k | -3,34% |
| 2026-03-01 | Mr. Michael EastonSenior VP of Finance & CAO | -27,84k | 64,03k | Sale to Issuer | 2,30 | 474,19k | -5,55% |
| 2026-03-01 | Mr. Jonathan M. CollinsExec. VP & CFO | -41,64k | 95,77k | Sale to Issuer | 2,30 | 391,90k | -9,60% |
| 2026-03-01 | Mr. Henry LevyPresident of Life Sciences & Healthcare | -37,34k | 85,89k | Sale to Issuer | 2,30 | 326,61k | -10,26% |
| 2026-02-18 | Mr. William E. GraffExec. VP & Chief Information Officer | -2,45k | 4,37k | Sale to Issuer | 1,78 | 619,81k | -0,39% |
| 2026-02-18 | Mr. Henry LevyPresident of Life Sciences & Healthcare | -18,12k | 32,24k | Sale to Issuer | 1,78 | 278,95k | -6,10% |
| 2026-02-18 | Mr. Michael EastonSenior VP of Finance & CAO | -3,52k | 6,27k | Sale to Issuer | 1,78 | 497,76k | -0,70% |
| 2026-02-18 | Mr. Jonathan M. CollinsExec. VP & CFO | -17,40k | 30,96k | Sale to Issuer | 1,78 | 338,04k | -4,89% |
| 2025-12-08 | Impactive Capital LPUnternehmen | -15,32M | 40,82M | Verkauf | 2,00 - 3,69 | 23,02M | -39,95% |
| 2025-12-31 | Mr. Andrew M. SnyderIndependent Non-Executive Chairman of the Board | -479,00 | 1,60k | Sale to Issuer | 3,34 | 391,34k | -0,12% |
| 2025-12-31 | Mr. Kenneth L. CornickIndependent Director | -2,40k | 8,01k | Sale to Issuer | 3,34 | 1,11M | -0,22% |
| 2025-12-31 | Ms. Jane Okun BombaIndependent Director | -243,00 | 811,62 | Sale to Issuer | 3,34 | 279,27k | -0,09% |
| 2025-12-01 | Mr. Bar VeinsteinPresident of Academia & Government | -309,90k | 1,16M | Automatic Disposition | 3,74 | 177,11k | -63,63% |
| 2025-11-15 | Mr. Michael EastonSenior VP of Finance & CAO | -50,52k | 174,80k | Sale to Issuer | 3,46 | 494,17k | -9,27% |
| 2025-11-10 | Mr. Kenneth L. CornickIndependent Director | 100,00k | 345,00k | Kauf | 3,45 | 1,10M | 9,97% |
| 2025-10-31 | Mr. Kenneth L. CornickIndependent Director | 725,00k | 2,48M | Kauf | 3,38 - 3,52 | 1,00M | 261,02% |
| 2025-10-31 | Cambridge Information Group, Inc.Unternehmen | 1,46M | 4,86M | Kauf | 3,33 | 25,60M | 6,05% |
| 2025-09-30 | Mr. Andrew M. SnyderIndependent Non-Executive Chairman of the Board | -419,00 | 1,60k | Sale to Issuer | 3,83 | 376,48k | -0,11% |
| 2025-09-30 | Ms. Jane Okun BombaIndependent Director | -18,00 | 68,94 | Sale to Issuer | 3,83 | 270,91k | -0,01% |
| 2025-09-30 | Mr. Kenneth L. CornickIndependent Director | -1,52k | 5,84k | Sale to Issuer | 3,83 | 277,76k | -0,55% |
| 2025-08-13 | Mr. Jonathan M. CollinsExec. VP & CFO | -140,65k | 599,15k | Sale to Issuer | 4,26 | 319,86k | -30,54% |
| 2025-08-15 | Mr. Jonathan M. CollinsExec. VP & CFO | -48,39k | 0,00 | Other Disposition | - | 319,86k | -13,14% |
| 2025-08-13 | Mr. William E. GraffExec. VP & Chief Information Officer | -23,53k | 100,22k | Sale to Issuer | 4,26 | 615,15k | -3,68% |
| 2025-08-13 | Mr. Matitiahu Shem TovCEO & Director | -90,66k | 386,22k | Sale to Issuer | 4,26 | 1,65M | -5,20% |
| 2025-08-13 | Mr. Henry LevyPresident of Life Sciences & Healthcare | -70,75k | 301,38k | Sale to Issuer | 4,26 | 260,22k | -21,38% |
| 2025-08-13 | Mr. Gordon SamsonInsider | -22,58k | 96,20k | Sale to Issuer | 4,26 | 775,25k | -2,83% |
| 2025-08-01 | Mr. Kenneth L. CornickIndependent Director | 165,00k | 617,10k | Kauf | 3,74 | 275,00k | 150,00% |
| 2025-06-30 | Ms. Jane Okun BombaIndependent Director | -306,00 | 1,32k | Sale to Issuer | 4,30 | 263,42k | -0,12% |
| 2025-06-30 | Mr. Andrew M. SnyderIndependent Non-Executive Chairman of the Board | -527,00 | 2,27k | Sale to Issuer | 4,30 | 363,52k | -0,14% |
| 2025-07-01 | Mr. Gordon SamsonInsider | -100,00k | 453,00k | Automatic Disposition | 4,53 | 744,07k | -11,85% |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
